Literature DB >> 28658717

Bone marrow-on-a-chip: Long-term culture of human haematopoietic stem cells in a three-dimensional microfluidic environment.

Stefan Sieber1,2, Lorenz Wirth1, Nino Cavak1, Marielle Koenigsmark1, Uwe Marx3, Roland Lauster1, Mark Rosowski1.   

Abstract

Multipotent haematopoietic stem and progenitor cells (HSPCs) are the source for all blood cell types. The bone marrow stem cell niche in which the HSPCs are maintained is known to be vital for their maintenance. Unfortunately, to date, no in vitro model exists that accurately mimics the aspects of the bone marrow niche and simultaneously allows the long-term culture of HSPCs. In this study, a novel three-dimensional coculture model is presented, based on a hydroxyapatite coated zirconium oxide scaffold, comprising of human mesenchymal stromal cells (MSCs) and cord blood derived HSPCs, enabling successful HSPC culture for a time span of 28 days within the microfluidic multiorgan chip. The HSPCs were found to stay in their primitive state (CD34+ CD38- ) and capable of granulocyte, erythrocyte, macrophage, megakaryocyte colony formation. Furthermore, a microenvironment was formed bearing molecular and structural similarity to the in vivo bone marrow niche containing extracellular matrix and signalling molecules known to play an important role in HSPC homeostasis. Here, a novel human in vitro bone marrow model is presented for the first time, capable of long-term culture of primitive HSPCs in a microfluidic environment.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  alternative to animal testing; bone marrow on a chip; ceramic scaffold; haematopoietic stem cells; mesenchymal stem cells; stem cell niche

Mesh:

Year:  2017        PMID: 28658717     DOI: 10.1002/term.2507

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  46 in total

1.  Deconstructed Microfluidic Bone Marrow On-A-Chip to Study Normal and Malignant Hemopoietic Cell-Niche Interactions.

Authors:  Julio Aleman; Sunil K George; Samuel Herberg; Mahesh Devarasetty; Christopher D Porada; Aleksander Skardal; Graça Almeida-Porada
Journal:  Small       Date:  2019-08-29       Impact factor: 13.281

Review 2.  Human-Derived Organ-on-a-Chip for Personalized Drug Development.

Authors:  Yasamin A Jodat; Min G Kang; Kiavash Kiaee; Gyeong J Kim; Angel F H Martinez; Aliza Rosenkranz; Hojae Bae; Su R Shin
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 3.  A human-on-a-chip approach to tackling rare diseases.

Authors:  Camilly P Pires de Mello; John Rumsey; Victoria Slaughter; James J Hickman
Journal:  Drug Discov Today       Date:  2019-08-11       Impact factor: 7.851

Review 4.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

Review 5.  Organ-on-a-Chip for Cancer and Immune Organs Modeling.

Authors:  Wujin Sun; Zhimin Luo; Junmin Lee; Han-Jun Kim; KangJu Lee; Peyton Tebon; Yudi Feng; Mehmet R Dokmeci; Shiladitya Sengupta; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2019-01-03       Impact factor: 9.933

6.  3D-printed miniaturized fluidic tools in chemistry and biology.

Authors:  C K Dixit; K Kadimisetty; J Rusling
Journal:  Trends Analyt Chem       Date:  2018-07-05       Impact factor: 12.296

7.  Microphysiological Systems: Next Generation Systems for Assessing Toxicity and Therapeutic Effects of Nanomaterials.

Authors:  Nureddin Ashammakhi; Mohammad Ali Darabi; Betül Çelebi-Saltik; Rumeysa Tutar; Martin C Hartel; Junmin Lee; Saber Hussein; Marcus J Goudie; Mercedes Brianna Cornelius; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  Small Methods       Date:  2019-11-11

8.  Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development

Authors:  Uwe Marx; Takafumi Akabane; Tommy B Andersson; Elizabeth Baker; Mario Beilmann; Sonja Beken; Susanne Brendler-Schwaab; Murat Cirit; Rhiannon David; Eva-Maria Dehne; Isabell Durieux; Lorna Ewart; Suzanne C Fitzpatrick; Olivier Frey; Florian Fuchs; Linda G Griffith; Geraldine A Hamilton; Thomas Hartung; Julia Hoeng; Helena Hogberg; David J Hughes; Donald E Ingber; Anita Iskandar; Toshiyuki Kanamori; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Bo Li; Peter Loskill; Donna L Mendrick; Thomas Neumann; Giorgia Pallocca; Ivan Rusyn; Lena Smirnova; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Sergej Tsyb; Martin Trapecar; Bob Van de Water; Janny Van den Eijnden-van Raaij; Paul Vulto; Kengo Watanabe; Armin Wolf; Xiaobing Zhou; Adrian Roth
Journal:  ALTEX       Date:  2020-02-28       Impact factor: 6.043

9.  How Qualification of 3D Disease Models Cuts the Gordian Knot in Preclinical Drug Development.

Authors:  Monika Schäfer-Korting; Christian Zoschke
Journal:  Handb Exp Pharmacol       Date:  2021

10.  Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics.

Authors:  Cristina E Tognon; Rosalie C Sears; Gordon B Mills; Joe W Gray; Jeffrey W Tyner
Journal:  Annu Rev Cancer Biol       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.